Tag: "viagra" at medical news

Viagra, unlikely tool for vision research, slows the visual response to flickering light

Therapeutic doses of Viagra have been shown to influence the rate at which visual signals are integrated by the brain, affecting the way quick, repeated events, such as flickering light, are perceived. The work sheds light on the function of a specific photoreceptor enzyme and paves the way for future research utilizing Viagra as a safe tool for studying human vision....... Originally developed a...

Viagra improves urinary tract symptoms in men with erectile dysfunction

Viagra (sildenafil citrate), known for improving erectile dysfunction (ED), also effectively treats the prostate and lower urinary tract symptoms (LUTS) associated with prostate enlargement that often occur with ED, a Northwestern University study has found. ... Kevin V. McVary, M.D., professor of urology at Northwestern University Feinberg School of Medicine, led the study, which he presented at...

Viagra blunts effects of stress on the human heart

Sildenafil citrate (Viagra), a drug used to treat erectile dysfunction (ED) in millions of men, reduces the stimulatory effects of hormonal stress on the heart by half, according to results of a new study by researchers at Johns Hopkins. ...... While sildenafil is more widely known for helping genital blood vessels expand to maintain an erection and, more recently, as a treatment for pulmonary h...

Sildenafil (Viagra) approved for treatment of pulmonary arterial hypertension (PAH) as Revatio

New York/Gieen. In a priority review the U.S. Food and Drug Administration (FDA) has approved Revatio () (sildenafil) as a treatment for pulmonary arterial hypertension (PAH). The FDA approval was based on the preceding experimental and clinical investigations, which were initiated and largely performed at the University of Giessen Lung Center (UGLC) and led to a worldwide multicenter study. ......
(Date:6/18/2013)... National Institutes of Health has awarded $12.7 million ... selection of pharmaceutical industry compounds to explore new ... Alzheimer,s disease, Duchenne muscular dystrophy and schizophrenia. The ... for Existing Molecules, is led by the National ... by the NIH Common Fund. , The process ...
(Date:6/18/2013)... June 18, 2013: The Association for Molecular Pathology is ... American Societies for Experimental Biology (FASEB) on July 1, ... on June 3, 2013. , The 26 constituent ... share a common vision for the advancement of research ... and translational research is more important now than ever," ...
(Date:6/18/2013)... that between 5% and 10% of breast and ovarian ... that these tumours are attributable to inherited mutations from ... In patients with these mutations, PARP inhibitors, which are ... make them a new option for personalised cancer treatment, ... indicate that a fraction of these patients generate resistance ...
Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2
Other Tags
adhdtemperamentnurtureentriesalchemymidasestablishingnationallytailoringteacherscouncildairydogsexistingadvocateenters